Alberston Pharmacy Inc Community/Retail Pharmacy Location: 1028 Willis Ave, Albertson, New York 11507 Phone: (516) 246-9900 |
Rite Aid Pharmacy #10611 Durable Medical Equipment & Medical Supplies Location: 1140 Willis Ave, Albertson, New York 11507 Phone: (516) 621-2466 |
Vision World Eyewear Supplier (Equipment, not the service) Location: 888 Willis Ave, Albertson, New York 11507 Phone: (516) 747-6363 |
Progressive O & P, Inc Prosthetic/Orthotic Supplier Location: 1111 Willis Avenue, Albertson, New York 11507 Phone: (516) 338-8585 |
News Archive
Though it's the more common form of the disease, sporadic Amyotrophic Lateral Sclerosis (ALS), which affects roughly 90 percent of those living with the fatal neurodegenerative illness, has been the one less studied, simply because, unlike familial ALS, no genes have turned up.
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune systems due to diseases like cancer are also at an increased risk of severe complications from the virus.
The basal ganglia is a series of highly connected brain areas localised deep in the cerebral cortex that recently has attracted interest of neuroscientists when it was linked to learning, and discovered to be affected in a number of disorders of the addictive and obsessive spectrum, but also in Parkinson's disease (PD). And now researchers think they have understood why as they found that neurons in this area signal the beginning and the end of voluntary actions. In fact, problems in these neurons could explain the "incapacity to stop" seen in obsession or compulsive behaviour, but also the problems in learning and control of movement characteristic of Parkinson's
Every animal starts as a clump of cells, which over time multiply and mature into many different types of cells, tissues, and organs.
OptiNose is pleased to announce the publication of results from its Phase II clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the topical treatment of chronic rhinosinusitis with nasal polyps in Rhinology, the official journal of the International and European Rhinologic Societies.
› Verified 3 days ago